氟伏沙明与马普替林的抗抑郁与抗焦虑作用的研究 |
| |
引用本文: | 贡永宁,郭平,郭华.氟伏沙明与马普替林的抗抑郁与抗焦虑作用的研究[J].中国当代医药,2010,17(6):48-49. |
| |
作者姓名: | 贡永宁 郭平 郭华 |
| |
作者单位: | 河南省驻马店市精神病医院,河南驻马店,463000 |
| |
摘 要: | 目的:探讨氟伏沙明治疗伴有焦虑症状的抑郁症的疗效与安全性。方法:将69例难治性抑郁症同时伴有焦虑症状的患者分为氟伏沙明组35例,马普替林组34例。观察8周,于治疗前和治疗后1、2、4及8周末采用汉密尔顿抑郁量表(HAMD-17)及汉密顿焦虑量表(HAMA)评定疗效。用副反应量表(TFSS)评定不良反应。结果:氟伏沙明组显效率为78%,马普替林组显效率为75%。氟伏沙明组不良反应相对较少。结论:氟伏沙明治疗伴发焦虑症状的抑郁症疗效较好,且起效快,不良反应少。
|
关 键 词: | 抑郁 焦虑 疗效 氟伏沙明 马普替林 |
A control study of fluvoxamine and maprotiline in the treatment of depression and anxiety |
| |
Authors: | GONG Yongning GUO Ping GUO Hua |
| |
Institution: | (Mental Hospital of Zhumadian Ctiy,Henan province,Zhumadian 463000,China) |
| |
Abstract: | Objective:To investigate the efficacy and safety of fluvoxamine in the treatment of patients with refractory depression and anxiety.Methods:A total of patients with refractory depression and anxiety were randomly assigned to 8 weeks treatment with fluvoxamine(n=35) or maprotiline(n=34) and changes from baseline in the Hamilton Rating Scale for Depression(HAMD-17),total scores of two groups,and Treatment Emergent Symptom Scale(TESS) were compared at 1 week before treatment and 1,2,4,8 weeks after treatment.Results:The significant efficacy rates of Fluvoxamine group was 78%,while that was 75% in the maprotiline group.There were less side effects in the Fluvoxamine group than the other group.Conclusion:Fluvoxamine is better thanmaprotilinein the treatment of refractory depression and anxiety,it shows better efficacy and less side effects.It is beneficial to improve the trerapeutic compliance of depressive patients. |
| |
Keywords: | Depression Anxiety Efficacy Fluvoxamine Maprotiline |
本文献已被 维普 万方数据 等数据库收录! |
|